rss
Thorax 63:1026
  • Letters
    • PostScript

Is the coprescription of β blockers and β2 agonists justified in COPD?

  1. A Singh
  1. Dr A Singh, Department of Pulmonary Medicine, Christian Medical College and Hospital, Ludhiana 141010, India; drsinghakashdeep{at}gmail.com

    Dransfield and colleagues1 advocate the use of β blockers even in patients admitted with acute exacerbations of chronic obstructive pulmonary disease (COPD), but certain points need further discussion.

    Their retrospective analysis highlights the discordance in practice that exists between cardiologist and pulmonologist. Indeed, the former is keen to commence β blockers in patients with a wide range of cardiovascular diseases …


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.